Pharmacorp Announces C$15 Million Bought Deal Offering
Pharmacorp Rx has secured a C$15 million bought deal to fuel its pharmacy roll-up strategy, selling 35.7 million units...
No videos found.
Trethera’s Breakthrough: $2.7M Grant for KRAS Resistance
Trethera has secured a $2.7 million NIH Small Business Innovation Research grant to evaluate its first-in-class DCK inhibitor, TRE-515,...
Athira Pharma Secures Cancer Drug with $236 Million Funding
Athira Pharma has licensed global rights (excluding Asia and certain Middle Eastern countries) to lasofoxifene from Sermonix Pharmaceuticals, positioning...
Outlook Therapeutics Reports FY 2025 Financial Results
Outlook Therapeutics posted fiscal 2025 results with its first commercial revenue from Lytenava, an ophthalmic formulation of bevacizumab for...
Sai Life Sciences Releases 2024-25 Sustainability Report
Sai Life Sciences has published its 2024–25 sustainability report, aligning with GRI Universal Standards 2021 and SASB, and outlining...
BioSyent Announces Renewal of Normal Course Issuer Bid
BioSyent has received TSX Venture Exchange approval to launch a normal course issuer bid allowing the company to repurchase...
Organogenesis Announces Promising Breakthrough for Knee OA Pain
Organogenesis has secured FDA alignment to begin a rolling Biologics License Application for Renu, a cryopreserved amniotic suspension allograft...
Singlera, Pitt Collaborate on Pancreatic Cancer Detection
Singlera Genomics and Breakthrough Genomics have initiated a research collaboration with the University of Pittsburgh to advance preclinical evaluation...
Peptinovo Announces Breakthrough in Targeted Chemotherapy
PeptiNovo Biopharma has secured a manufacturing and IP milestone that could unlock clinical entry for its targeted chemotherapy platform,...
Dyadic, Fermbox Bio Expand Animal-Free Protein Partnership
Dyadic Applied Biosolutions has expanded its collaboration with Fermbox Bio, granting Fermbox rights to manufacture and commercialize multiple Dyadic-origin...